Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.

Ionis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...

The U.S. Health Department plans to cut 10,000 jobs, impacting agencies such as the FDA, CDC, NIH, and Medicare. Read more ...

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

Biogen Inc. (NASDAQ: BIIB) has unveiled plans for its new global headquarters in Cambridge, located across the Charles River from Boston. The biotechnology company has selected Kendall Common, located ...

Biogen Inc. closed 41.53% short of its 52-week high of $238.00, which the company achieved on July 12th.

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

From Feb. 19, 2020, to March 23, 2020, the S&P 500 dropped from 3,386.10 to 2,237.40, losing 33.9% of its value. The global outbreak of COVID-19 understandably rattled financial ...

The biotech company plans to move into the new development in 2028, consolidating other leased and owned spaces in the ...

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...

The facility, which is set to open amid Biogen’s 50th anniversary, will integrate research and development, technical ...

Biogen Inc. will relocate its headquarters to MIT’s new Kendall Square development after leasing 580,000 square feet in the ...